About the bill
H.R. 5353 authorizes the Centers for Disease Control (CDC) to undertake an injection drug-use associated infection elimination initiative and work with states to improve education, surveillance, and treatment of infections associated with injection drug use.
Sponsor and status
Sponsor. Representative for New Jersey's 7th congressional district. Republican.
Last Updated: Jun 13, 2018
Length: 5 pages
115th Congress (2017–2019)
This bill was introduced in a previous session of Congress and was passed by the House on June 12, 2018 but was never passed by the Senate.
Although this bill was not enacted, its provisions could have become law by being included in another bill. It is common for legislative text to be introduced concurrently in multiple bills (called companion bills), re-introduced in subsequent sessions of Congress in new bills, or added to larger bills (sometimes called omnibus bills).
14 Cosponsors (7 Republicans, 7 Democrats)
What legislators are saying
“Lance Delivers: New Jersey Sees $13 million in new funding to combat opioids”
— Rep. Leonard Lance [R-NJ7, 2009-2018] (Sponsor) on Apr 19, 2018
“Greg Walden shepherds 25 bills through House of Representatives to combat nationwide opioid crisis”
— Rep. Greg Walden [R-OR2, 1999-2020] (Co-sponsor) on Jun 12, 2018
“Cramer: house passes major legislation to combat the opioid crisis”
— Sen. Kevin Cramer [R-ND] on Jun 13, 2018
More statements at ProPublica Represent...
What stakeholders are saying
Mar 20, 2018
Bills and resolutions are referred to committees which debate the bill before possibly sending it on to the whole chamber.
Apr 25, 2018
Considered by Health
A committee held a hearing or business meeting about the bill.
May 9, 2018
A committee has voted to issue a report to the full chamber recommending that the bill be considered further. Only about 1 in 4 bills are reported out of committee.
Jun 12, 2018
Passed House (Senate next)
The bill was passed in a vote in the House. It goes to the Senate next. The vote was by voice vote so no record of individual votes was made.
H.R. 5353 (115th) was a bill in the United States Congress.
A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.
Bills numbers restart every two years. That means there are other bills with the number H.R. 5353. This is the one from the 115th Congress.
This bill was introduced in the 115th Congress, which met from Jan 3, 2017 to Jan 3, 2019. Legislation not passed by the end of a Congress is cleared from the books.
How to cite this information.
We recommend the following MLA-formatted citation when using the information you see here in academic work:
GovTrack.us. (2023). H.R. 5353 — 115th Congress: Eliminating Opioid Related Infectious Diseases Act of 2018. Retrieved from https://www.govtrack.us/congress/bills/115/hr5353
“H.R. 5353 — 115th Congress: Eliminating Opioid Related Infectious Diseases Act of 2018.” www.GovTrack.us. 2018. March 31, 2023 <https://www.govtrack.us/congress/bills/115/hr5353>
Eliminating Opioid Related Infectious Diseases Act of 2018, H.R. 5353, 115th Cong..
|title=H.R. 5353 (115th)
|accessdate=March 31, 2023
|author=115th Congress (2018)
|date=March 20, 2018
|quote=Eliminating Opioid Related Infectious Diseases Act of 2018
- show another citation format:
- Blue Book
- Wikipedia Template
Where is this information from?
GovTrack automatically collects legislative information from a variety of governmental and non-governmental sources. This page is sourced primarily from Congress.gov, the official portal of the United States Congress. Congress.gov is generally updated one day after events occur, and so legislative activity shown here may be one day behind. Data via the congress project.